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No superiority of cemented metal-on-
metal over metal-on-polyethylene total 
hip arthroplasty in a randomized trial at 
10-year follow-up
Orthopedics 2010;33:154-161
It komt er net op oan hoe âld men is, mar hoe’t men ald is.
Het komt er niet op aan hoe oud men is, maar hoe men oud is.
Wierd P. Zijlstra




In a randomized controlled trial, 102 cemented Stanmore 28-mm metal-on-metal 
total hip arthroplasties (THAs) were compared to 98 metal-on-polyethylene THAs in 
195 patients. At a mean follow-up of 10 years, 11 patients (11 hips) were lost to follow-
up, 53 patients (55 hips) died, and 6 patients (6 hips) underwent revision. Average age 
of the surviving patients was 79 years. Harris Hip Scores and Oxford Hip Scores had 
increased significantly in both groups (p<.001). Ten years postoperatively, mean Har-
ris Hip Score was 86 in the metal-on-metal patients and 87 in the metal-on-polyethy-
lene patients (p=.441); Oxford Hip Scores were 27 and 24, respectively (p=.494). Wear 
was present in 30 of 52 polyethylene cups. Periprosthetic radiolucencies were seen in 
57% of the metal-on-metal patients and in 52% of the metal-on-polyethylene patients 
(p=.680); they were mainly seen in DeLee & Charnley’s zones 1 and 2. Serum cobalt 
and chromium concentration were higher in the metal-on-metal group (cobalt 1.1, chro-
mium 1.0 vs 0.5 and 0.5 μg/L, respectively; p<.001). Patients with high ion levels (maxi-
mum 9.5 and 11 μg/L, respectively) all showed high Harris Hip Scores and few or no 
periprosthetic radiolucencies, and none were revised. Ten-year survival was 95.5% in 
the metal-on-metal group (4 revisions) and 96.8% in the metal-on-polyethylene group 
(2 revisions; p=.402). All revisions were indicated for aseptic loosening. One case of 
aseptic lymphocytic vasculitis-associated lesions (ALVAL) and no pseudotumors were 
observed. The absence of clinical superiority of the cemented metal-on-metal bearing 




The long-term results of total hip arthroplasty (THA) are hampered by polyethylene 
wear which can lead to osteolysis and eventually failure of the implant.1 Metal-on-metal 
(MM) articulation is an alternative bearing with a reduced wear rate. It was widely used 
between 1960 and 1975. MM articulation was discouraged by the early success of 
the Charnley prosthesis and the high loosening rate of the McKee-Farrar and other 
first-generation MM hips.2 The emerging adverse reactions of polyethylene wear lead 
a resurgence of metal-on-metal articulations in the early 1990s. Improved wear-perfor-
mance was achieved by modifications in metallurgy, sphericity and radial clearance in 
second-generation MM articulations.3,4 It is hypothesized that the reduction in prosthetic 
wear would lead to less osteolysis and superior prosthetic survival. Indeed, studies have 
reported negligible osteolysis in well-fixed components.2,5-7 
However, metal-on-metal arthroplasty has not demonstrated clinical superiority over 
metal-on-polyethylene articulation yet,8 regardless of favourable hip simulator study 
results. Moreover, reports regarding the outcome of cemented second-generation MM 
prostheses are scarce9-11 and randomized controlled trials (RCT) and long-term follow-
up studies are lacking.
Our objective was to evaluate and compare cemented total hip prostheses with a 
metal-on-polyethylene articulation (MP) with prostheses with a metal-on-metal articu-
lation (MM). The metal inlay in the cup of the MM articulation was the only difference 
between both prostheses. Clinical performance was the primary outcome. Radiological 
performance, serum metal ion analysis and prosthetic survival were secondary outcome 
measures. We hypothesized equal clinical performance of the two bearings. The aim of 




Consecutive patients with non-inflammatory degenerative hip joint disease including 
osteoarthritis, avascular necrosis and traumatic arthritis were included. Exclusion criteria 
were active infection, revision arthroplasty, marked bone loss precluding adequate fixa-
tion, unwillingness or inability to follow instruction, severe vascular insufficiency of the 
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The randomization procedure was based on sequentially numbered opaque sealed 
envelopes, produced by an external institution not involved in the selection, care and 
evaluation of the patients. The local Medical Ethical Committee approved the study de-
sign and procedures (registration number 97-19). Informed consent was obtained in all 
patients. The trial was conducted in compliance with the Helsinki Declaration. 
Operative technique and implants
The surgeries were performed in 1998 and 1999 by five orthopaedic surgeons and two 
orthopaedic residents. Both the posterolateral and direct lateral approach were used. 
Antibiotic prophylaxis with a first-generation cephalosporin was given for twenty-four 
hours intravenously. We used third-generation cementing techniques. Postoperative 
analgesia and mobilization adhered to a standardized protocol in all patients. An oral 
coumarin-derivate was given for 6 weeks postoperatively. 
The MM Stanmore cup (M2A®, Biomet, Warsaw, United States of America) was manu-
factured by moulding a block of ultra-high molecular weight polyethylene (UHMWPE) 
around a highly polished cobalt-chromium-molybdenum alloy bearing insert, meeting 
ASTM F1537 requirements. The MP acetabular components were standard Stanmore 
cups made from UHMWPE, packaged in an Argon environment and sterilized with gam-
ma irradiation. This polyethylene was not highly cross-linked. Both types of acetabular 
components were available in sizes from 40 to 57 mm. The 28-mm head used in all 
cases had a radial clearance of 30 to 60 μm and was made of cobalt-chromium-molyb-
denum alloy. This head had various neck lengths if necessary. The Stanmore femoral 
stem had a straight (straight stem) or slightly curved contour (standard stem) and a satin 
surface finish with a roughness of 0.8 μm Ra. The stem was made from forged cobalt-
chromium-molybdenum alloy; five sizes were available.
Clinical scores, radiographic evaluation, metal ion analysis
Patients were assessed pre-operatively with the Harris Hip Score (HHS)13,14 and the 
Oxford Hip Score.15 All patients returned for follow-up at regular intervals, at least annu-
ally. HHS and Oxford Hip Scores were scored at 1, 5 and 10 years postoperatively. The 
examiners were not blinded.
At each follow-up visit supine anteroposterior (AP) pelvic hip radiographs (115% magni-
fication) were taken. See Figure 1 for an example. At the 10 year follow-up, radiographs 
of the stems were reviewed for presence of radiolucent lines and scored according to 
Gruen et al.16 and periacetabular radiolucencies were assessed according to De Lee 
and Charnley.17 Radiological loosening and migration were noted if present. Scoring was 
48
undertaken by a senior orthopaedic registrar (WPZ) and a senior orthopaedic surgeon 
(JJAMVR) and consensus was sought.
Figure 1: Stanmore metal-on-
metal (right) and metal-on-pol-
yethylene (left) THAs at 10- and 
9-year follow-up, respectively.
In a subgroup of patients, venous blood samples were taken.  Cobalt ion concentra-
tions were determined preoperatively and 5 and 10 years postoperatively; chromium ion 
concentrations were only measured 10 years postoperatively. We used inductively cou-
pled plasma mass spectrometry (ICP-MS; Agilent 7500 Series, Agilent Technologies, 
United States of America ) and grafite furnace atomic absorption spectrophotometry 
with Zeeman correction (GFAAS; Varian 220Z, Varian Inc., United States of America). 
The reference values of our laboratory were <6.8 nmol/l (0.40 μg/l) for cobalt and <48 
nmol/l (2.50 μg/l) for chromium.
Statistical analysis 
In order to detect a least clinical relevant difference in Harris Hip Score of 5 points in 
a non-inferiority design with a standard deviation of 12, 144 hip arthroplasties were 
needed (alpha 0.05, power 0.80). To compensate for death and loss to follow-up, 100 
hip arthroplasties in each group were aimed for. 
We used the Statistical Package for the Social Sciences (SPSS Inc, Chicago, USA). 
Non-parametric tests were used for comparisons of means within groups (Wilcoxon’s 
Signed Ranks test) and between groups (Mann-Whitney test). Chi-square (Fisher’s 
Exact) tests were employed for analysis of categorical variables. Prosthetic survival was 
calculated by Kaplan-Meier time series (Mantel-Cox log rank test). A two-sided p-value 
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Ninety-eight metal-on-polyethylene articulations and 102 metal-on-metal articulations 
were allocated to 195 patients. Five patients underwent staged bilateral hip replace-
ments (1 MM/MM, 1 MP/MP, 3 MM/MP). No differences were present between the 
patients groups in terms of gender, operated side, preoperative HHS and Oxford Hip 
Score (Tables 1 and 3). Mean age at operation was higher in the MM group. 
In 2008 and 2009, on average 10 years after surgery, all patients were contacted to 
come in for review. Fifty-three patients (55 hips) had died of non-related causes. The 
number of deaths did not differ between the 2 prosthetic groups (Chi-Square Fisher’s 
Exact test, p=0.528). Eleven patients (11 hips) had moved or were lost to follow-up. 
Eight patients (8 hips) did not want to cooperate anymore. Eighteen patients (18 hips) 
were not able to come to the hospital due to severe medical problems. In none of these 
patients was revision performed or pending. Six patients (6 hips) needed revision sur-
gery. Consequently, a total of 102 hips (55 MP, 47 MM; 99 patients) remained for follow-
up at an average of 121 + 4 months (range 109-128); see Table 2.
Clinical outcome
Both groups improved significantly (Table 3). Harris hip and Oxford hip scores at 10-year 
follow-up did not differ between the two groups. Eleven out of the eighteen patients with 
severe medical morbidity were reviewed by Oxford scores alone since they were unable 
to attend the clinic.
MP MM Total P-value
Number of hips 98 102 200
Male/female † 20/78 21/81 41/159 1.000
Side (right/left) † 57/41 56/46 113/87 0.671
Mean age (standard devia-
tion) in years ‡
69 (8) 72 (7) 71 (8) 0.018
†P-values were calculated by Chi-Square (Fisher’s Exact) tests.
‡P-values were calculated by Mann-Whitney tests.
Table 1. Preoperative demographics in the metal-on-polyethylene (MP) and metal-on-metal (MM) 
groups.
50
Table 2. Number of hips included and followed-up in the metal-on-polyethylene (MP) and metal-
on-metal (MM) groups.
MP MM
Randomized and operated 98 102
Died (not related to surgical procedure) 25 30
Lost to follow-up 4 7
Refused cooperation 4 4
Unable due to comorbidity 8 10
Revised 2 4
Remaining for follow-up (mean 121 +/- 4 months) 55 47
Table 3. Mean and standard deviation of the Harris Hip (HHS) and Oxford Hip Scores in the 
metal-on-polyethylene (MP) and metal-on-metal (MM) groups, pre-operatively and at follow-up.
MP MM P-value †
HHS Oxford HHS Oxford HHS Oxford
Preoperatively 46 (13) 40 (8) 48 (15) 40 (8) 0.746 0.661
1 yr 85 (13) 18 (7) 86 (8) 19 (8) 0.446 0.461
5 yr 87 (13) 18 (8) 90 (7) 19 (8) 0.791 0.515
10 yr 87 (10) 24 (9) 86 (10) 27 (13) 0.441 0.494
P-value‡ <0.001 <0.001 <0.001 <0.001
†P-values between groups were calculated by Mann-Whitney tests.
‡ P-values within groups were calculated by Wilcoxon’s Signed Rank tests (preoperatively versus 10 yr).
Complications
One femoral shaft perforation occurred intra-operatively without long-term clinical se-
quelae (MP group). There were 6 hematomas, 5 superficial wound infections (none of 
these patients needed revision), and 1 posterior dislocation without further sequelae. 
Cardiovascular and urogenital events occurred in 12 patients. Two patients (1 MP, 1 
MM) suffered a periprosthetic femoral fracture 5 years postoperatively. These were treat-
ed with osteosynthesis; revision was not needed. Long-term clinical improvement was 
seen in both patients.
Radiological outcome
After 10 years no focal osteolysis was seen, but radiolucent lines were noted especially 
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4). Statistical analysis revealed no differences between the groups. Two cups (1 MM, 1 
MP) were radiologically loose according to the Zicat criteria,18 but these patients had no 
complaints (HHS 81 and 83). All other cups were stable. Polyethylene wear was noted 
in 30 of the 52 polyethylene cups.
Serum cobalt and chromium analysis
Postoperative cobalt and chromium concentrations were significantly higher in the MM 
group. Median cobalt concentration increased 2.1 times in the metal-on-polyethylene 
group and 6.1 times in the metal-on-metal group (Table 5). One patient showed cobalt 
levels of 7.0 μg/l at the 5-year follow-up. Her HHS was 88, her Oxford-score 12 and 
she showed no periprosthetic radiolucencies at 5 years. At the 10 year review she 
was not able to come to the hospital due to comorbidity (mamma carcinoma) but her 
Oxford-score was 14. One patient presented with a cobalt level of 11 μg/l and a chro-
mium level of 9.5 μg/l at the 10 year follow-up. She had no complaints, her HHS was 
95, her Oxford-score 14 and no radiolucencies were seen. All other 10 year cobalt and 
chromium levels were below 2.5 μg/l. None of these patients needed revision surgery.
Table 4. Number of hips showing radiolucent lines on standard anteroposterior pelvic hip radio-
graphs on average 10 years postoperatively.
Zone MP MM P-value*
N=52 N=42
Stem (Gruen)
1 5 6 0.532
2 0 1 0.447
3 0 1 0.447
4 1 0 1.000
5 0 0 -
6 0 0 -
7 4 0 0.125
Cup (De Lee & Charnley)
1 17 13 1.000
2 16 9 0.495
3 9 8 1.000
Number of hips with a radiolucency 27 (52%) 24 (57%) 0.680
*Chi-Square (Fisher’s Exact) tests were used to test for statistical differences between the metal-on-metal 
(MM) and metal-on-polyethylene (MP) groups.
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Table 5. Median and range of the serum cobalt and chromium concentrations (μg/L) in the metal-
on-polyethylene (MP) and metal-on-metal (MM) groups, preoperatively and at follow-up.
MP MM P-value†
N=13* N=17*
Median Range Median Range
Preoperatively (cobalt) 0.24 0.18-0.65 0.18 0.18-1.77 0.185
5 yr (cobalt) 0.30 0.29-1.65 0.88 0.29-7.02 0.001
10 yr (cobalt) 0.50 0.40-1.30 1.10 0.50-11.0 <0.001
10 yr (chromium) 0.50 0.50-0.90 1.00 0.50-9.5 <0.001
P-value‡ 0.037 0.042
*N is the number of hips at 10 year follow-up; preoperatively N was 24 MM versus 19 MP 
†P-values between groups were calculated by Mann-Whitney tests.
‡ P-values within groups were calculated by Wilcoxon’s Signed Rank tests (cobalt preoperatively versus 
10 yr).
Analysis of revisions 
All 6 revisions (4 MM, 2 MP) were undertaken because of aseptic loosening. In the MP 
group one patient was revised after 21 months because of pain associated with radio-
lucent reactions surrounding the stem. All prosthetic material was removed. A cemented 
THA using bone impaction grafting was implanted. In a second MP patient radiographic 
loosening was noted of both the stem and cup after nine years. A total revision was 
performed ten years postoperatively.
The first MM acetabular revision surgery was performed at 26 months postoperatively 
for pain and emerging radiolucent lines around the cup. The second patient had a 2 x 
3 cm cyst in the cranial acetabulum that was initially treated by excavation and cement 
filling. Three months postoperatively a radiolucent zone in this area emerged, suggest-
ing insufficient initial fixation of the MM cup. At revision operation 33 months post-
operatively, the cup was loose. The third patient suffered from protrusio acetabuli and 
arthrosis. Two and three years postoperatively recurrent posterior dislocations occurred. 
Fifty-six months postoperatively, X-rays showed a cyst cranial to the MM acetabular 
component in the prior protrusion region and subtle migration. The loose cup was re-
vised. The femoral component was well-fixed in all the above patients. The fourth patient 
had a history of tuberculosis in both her lung and hip but had been asymptomatic for at 
least 15 years. Intra-operative cultures and histology ruled out infection and tuberculo-
sis at the time of implantation of the MM hip. Seven years postoperatively progressive 
radiolucencies were noted and a Girdlestone hip was created due to insufficient bone-
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In all of the revision cases infection was ruled out by culture and/or histology. Lympho-
cytic infiltration was seen in only one case (the second MM revision described above). 
In this patient’s periprosthetic tissues, eosinophiles and macrophages were also seen. 
Macrophage presence was noted in two other patients as well (1 MP, 1 MM). Giant cell 
proliferation was described in one case (the first MM patient above). 
Survivorship
Survival at 10 years (revision for any reason as well as aseptic loosening was 95.5% 
in the metal-on-metal group (95%-confidence interval (CI) 91.2-99.8%; 37 patients at 
risk) and 96.8% for the metal-on-polyethylene articulation (95%-CI 92.3-100%; 46 pa-
tients at risk). There were no significant differences between the two survival curves 
(Mantel-Cox log rank test, p=0.402). The survival rates for the acetabular component 
were similar. Stem survival was 98.6% (95%-CI 96.1-100%) in the metal-on-metal group, 
and 96.8% (95%-CI 92.3-100%) in the metal-on-polyethylene group (any reason as well 
as aseptic loosening; Mantel-Cox log rank test, p=0.606). Assuming that all patients lost 
to follow-up (including those that had moved, were unable to attend the clinic or did not 
want to cooperate anymore) were also failures, the worst-case 10-year survival was also 
calculated:19 MM survival was 80.5% (95%-CI 70.9-90.1%) and MP survival was 86.2% 
(95%-CI 77.6-94.8%). This difference was not statistically significant.
DISCUSSION
The objective of the present randomized controlled trial was to evaluate and compare 
cemented metal-on-metal total hip articulations with metal-on-polyethylene articula-
tions. Both articulations lead to significant clinical improvements. At 10-year follow-up, 
Harris and Oxford hip scores did not differ between the two groups. Focal osteolysis was 
not observed. Periprosthetic radiolucent lines were mainly seen in De Lee & Charnley’s 
zone 1 and 2 and the  frequency of radiolucencies did not differ statistically between the 
two articulations. Ten-year prosthetic survival was 95.5% (4 revisions) for the metal-on-
metal articulation and 96.8% for the metal-on-polyethylene articulation (2 revisions), with 
no statistically significant difference. 
We aimed to compare metal-on-metal and metal-on-polyethylene articulations as com-
parative studies on cemented second-generation metal-on-metal total hip arthroplasty 
were scarce at the time of conception of our study.20 In our clinic, we have been using 
the Stanmore metal-on-polyethylene prosthesis since 1975.21, 22 We have shown survival 
to be 85% at 22 years.23 By only changing the metal inlay in the cemented cup we could 
ensure that the only varying parameter was the articulation and we could eliminate learn-
ing curves or prosthetic design failures.
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Our study suffers from limitations. Our patients were relatively old at the time of entry into 
the trial. Many patients therefore died before the 10-year review. The surviving patients 
were 79 years old on average, and quite a few patients were unable to visit the clinic due 
to co-morbidity. Some could be reviewed via the Oxford questionnaires. One can argue 
that our total of 102 hips remaining for follow-up is less than the calculated sample size 
of 144 that was needed tot detect a 5 point difference in Harris Hip Score. HHS stan-
dard deviation at 10 years was 10 however instead of the assumed 12. This means that 
51 hips in each group were sufficient to detect a 5 point difference. 
With respect to clinical improvement and survival our results are comparable to other 
reports. Dorr et al. analyzed 70 Metasul metal-on-metal articulations with a cemented 
Weber cup. 9 Survival was 98% at 5.2 years in 56 patients; average HHS was 90 points. 
Acetabular osteolysis was not seen, but calcar resorption was noted in two hips. A 94% 
survival at 3.7 years follow-up was shown by Levai et al., describing 122 cemented 
Metasul metal-on-metal hips.10 They noted radiographically probable loosening in 11 
hips and when the patients with progressing radiolucencies were taken into account 
the calculated 5-year survival decreased to 80%. This group therefore discontinued 
cementing the Metasul cup. Eswaramoorthy et al. describe 6 revisions in 85 Metasul 
metal-on-metal hips at 10.8 years follow-up.11 A cemented cup was implanted in half 
of the subjects. Survivorship was 94% at ten years. Lazennec recently described their 
9-year results for the cemented Metasul cup.24 Survival rates were between 89% (re-
vision for any reason) and 91% (revision for aseptic cup loosening). This group stopped 
using the cemented metal-on-metal cup.
Cementless metal-on-metal total hip arthroplasties have been tested in RCTs and have 
shown satisfying short and medium-term results. Lombardi et al. reported the 5-year 
results of 53 metal-on-metal versus 46 metal-on-polyethylene THAs.25, 26 Survival rate 
was 100% at 5.7 years in both groups; radiological and clinical differences were absent. 
MacDonald et al. showed equal clinical and radiological performance of 18 cement-
less metal-on-metal THAs compared to 23 metal-on-polyethylene THAs.27 After a mean 
follow-up of 3.2 years, survival was 100% in both groups. Jacobs et al. reported good 
clinical results and equal radiological outcome in 95 Ultima metal-on-metal cups com-
pared to 76 polyethylene cups.28 In all, none of the studies proved superiority of the 
metal-on-metal bearing over polyethylene. 
From a tribological point of view, the main advantages of metal-on-metal over conven-
tional metal-on-polyethylene are the low wear-rate and the use of larger, more stable 
heads. Several factors appear crucial for this low wear performance. Hip simulator and 
retrieval studies have shown that metal-on-metal wear rates decrease with increasing 
head size (>40mm), low radial clearance (120-200 μm) and high carbon content.29 The 
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high (0.2-0.3%), but the 28mm articulation may not have developed the optimal fluid 
film lubrication necessary for low wear-rates. We were unable to measure wear in our 
metal-on-metal articulations as this is impossible through conventional radiographs. We 
did see wear in a large proportion (30/52) of the metal-on-polyethylene articulations. The 
polyethylene used was not highly-crosslinked. Had this been the case, the observed 
polyethylene wear might have been less. The frequent presence of polyethylene wear 
indicates its fragility in long-term usage. 
The value of periprosthetic radiolucencies in metal-on-metal articulations remains open 
to debate. A high number of these lucencies were present in both the metal-on-poly-
ethylene (52%) and the metal-on-metal articulations (57%). Focal osteolysis was not 
seen. Lazennec found radiolucent lines and osteolysis in 26% of the cemented Meta-
sul cups after 9 years.24 The higher age and thus inferior bone quality of our patients 
may partly explain these lucencies, as may cementing technique and initial fixation. 
Higher friction torques generated by the metal-on-metal articulation may stress the bone 
cement interface more than in metal-on-polyethylene articulation. Whether these lucen-
cies are suggestive of future cup failures remains to be seen in the next 5 years.
High serum metal ion concentrations may indicate failure of a metal-on-metal implant. 
Hence we monitored systemic cobalt and chromium levels. Median serum cobalt con-
centration at 10-year follow-up was 1.10 μg/l in the metal-on-metal bearings and 0.50 
μg/l in the metal-on-polyethylene bearings; medium chromium concentration was 1.00 
and 0.50 μg/l, respectively. Brodner et al. found a 0.7 μg/l cobalt concentration after 5 
years30 and 0.75 μg/l after 10 years.31 Lazennec reported cobalt levels of 1.55 μg/l and 
chromium levels of 1.49 μg/l after 9 years.24 We could not relate cobalt or chromium 
concentration to periprosthetic radiolucency or prosthetic failure. Although the observed 
systemic cobalt and chromium levels may inhibit osteoblast proliferation in vitro by as 
much as 18% (personal data), our patients seemed to tolerate this well. Patients with 
high ion levels all showed high Harris Hip scores, few or no periprosthetic radiolucen-
cies, and none were revised. 
Biologic effects of the submicron metal-on-metal wear particles are under growing in-
vestigation and concern.8, 32, 33 Metal allergy, metal sensitivity, and chromosomal damage 
are described. Metal sensitivity refers to a type IV delayed-type hypersensitivity reaction 
and we have reported this phenomenon earlier.34 The histologic features are described 
as aseptic lymphocytic vasculitis-associated lesions (ALVAL).35 In one of our four revised 
MM patients lymphocyte, eosinophile and macrophage infiltration was described, sug-
gesting possible ALVAL. In the other cases these characteristics were not mentioned, 
but ALVAL was not that well recognized at the time. 
We compared cemented second-generation metal-on-metal total hip arthroplasty to 
metal-on-polyethylene hip arthroplasty in a randomized controlled trial. At 10 years fol-
56
low-up both prostheses lead to significant but equal clinical improvement. Cobalt and 
chromium serum levels were higher in the metal-on-metal patients. We did not observe 
fewer periprosthetic radiolucencies with the metal-on-metal bearing, nor did we see 
enhanced prosthetic survivorship. The absence of clinical superiority of the cemented 
metal-on-metal bearing and the concerns over their biological effects have lead us to 
favor the cemented metal-on-polyethylene total hip arthroplasty in our clinic.
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ÛÛnder in steand seil is it maklik kloetsjen.
Onder een staand zeil is het gemakkelijk bomen.
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